期刊文献+

胡麻籽提取物对大鼠动脉粥样硬化的防治作用 被引量:2

原文传递
导出
摘要 为了观察胡麻籽提取物(EFS)对大鼠动脉粥样硬化的防治作用,试验采用高脂饮食建立大鼠动脉粥样硬化模型,测定正常对照组、高脂模型组、胡麻籽提取物低剂量组(0.25 g/m L)、胡麻籽提取物中剂量组(0.50 g/m L)、胡麻籽提取物高剂量组(1.00 g/m L)血清中总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)含量。结果表明:与高脂模型组相比,EFS中剂量组、高剂量组血清中TC、TG含量极显著降低(P<0.01),HDL-C含量显著提高(P<0.05),动脉粥样硬化指数极显著降低(P<0.01)。说明EFS具有一定的调节血脂及抗动脉粥样硬化的作用。
机构地区 河北北方学院
出处 《黑龙江畜牧兽医(下半月)》 CAS 北大核心 2015年第8期138-139,共2页
基金 张家口市科学技术和地震局资助(1112015C-5)
  • 相关文献

参考文献8

  • 1松沢佑次,垂井清一郎,于哲夫.动脉粥样硬化发病机理[J].国外医学(老年医学分册),1989,10(4):145-148. 被引量:2
  • 2杨久亮.动脉粥样硬化发病机制的研究进展[J].人民军医,2003,46(8):484-486. 被引量:6
  • 3DWIVEDI C, NATARAJAN K, MATI'HEES D P. Chemopreventive effects of dietary flaxseed oil on colon tumor development ~ J ]. Nutr Cancer,2005,51 ( 1 ) :52- 58.
  • 4TZANG B,S,YANG S F;FU S G, et al. Effects of dietary flaxseed oil on cholesterol metabolism of hamsters[ J ]. Food Chem,2009,114 (4) : 1450 - 1455.
  • 5GUILGUERRERO J L,BELARBI E H. 3, -Linolenic acid purifica- tion from seed oil sources by argentated silica, gel chromatography colum[ J]. Process Biochem,2000,36(4) :341 -354.
  • 6RIEDIGER N D, AZORDEGAN N, HARRIS - JANZ S, et al. ' De- signer oils'Low n -6:n -3 fatty acid ratio, with fish or flaxseed oil, in a high fat diet improves plasma lipids and beneficially alters tis- sue fatty acid composition in mice [ J ]. Eur J Nutr, 2009,48 ( 5 ) : 307 -314.
  • 7李璇,郑建仙.脂肪与心血管疾病相互关系最新进展及对食品工业的指导意义[J].食品与发酵工业,1998,24(1):74-79. 被引量:42
  • 8ANDO K, NAGATA K, YOSHIDA R, et al. Effect of n - 3 polyun- saturated fatty acid supplementation on lipid peroxidation of rat or- gans[J]. Lioids,2000,35(4) :401 -407.

二级参考文献12

  • 1Towbin JA. The role of cytoskeletail proteins in cardiomy OP thies, opinion Cell Biol,1998,10(1):131.
  • 2Qiao JH, Tripathi J, Mishra NK et al. Role of macrphage colony stimulating factor in atherosclerosisz studies of osteopetrotic etrotic mice. Am I Pathol. 1997.150.1687.
  • 3Wang J,Wang S,Lu Y et al. GM-CSF and M-CSF expression is associaeed with macrophage proliferation in progressing and regressing rabbit atherolmatous lesions.Exp Mol Pathol, 1994,61:109.
  • 4Mozes G, Mohacsi F, Glovizki Pet al. Adenovirus-Mediated gene transfer of macrophage colony stimulating factor to the arterial wall in vivo. Arteroscler Thromb Vasc Bio1,1998,18,1157.
  • 5Simonnet WS, Lacey DL, Dunstan CR et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.Cell, 1997,89:309.
  • 6Bucay N, Sarosi I, Dunstan CR et al. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev, 1998,12: 1260.
  • 7Min H,Morony S,Sarosi I et al. Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteclastogensis. J Exp MED,2000,192:463.
  • 8Hovoet P,Collen D. Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis. Atherosclerosis, 1998,137(Suppl):33.
  • 9Vlad M,caseanu E, Uza Get al. Concentration of copper, zinc,chromium,iron and nickel in the abdominal aorta of patients deceased with coronary heart disease. J Trace Elem Electrolytes.Health Dis, 1994,8:111.
  • 10张钧华.血管内皮功能障碍与冠状动脉疾病[J].中华老年心脑血管病杂志,2002,4(1):3-5. 被引量:69

共引文献47

同被引文献46

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部